ArticleAge and ageing2022
European Working Group on Sarcopenia in Older People 2010 (EWGSOP1) and 2019 (EWGSOP2) criteria or slowness: which is the best predictor of mortality risk in older adults?
Article in Age and ageing, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Measurement properties of the usual and fast gait speed tests in community-dwelling older adults: a COSMIN-based systematic review.Age and ageing · 2024Pooled it
- Factors associated with sarcopenia and exploratory thresholds for low muscle strength in people living with the human immunodeficiency virus.BMC infectious diseases · 2026Article
- Multimodal Therapeutic Strategies for the Management of Sarcopenia and Frailty in Chronic Obstructive Pulmonary Disease: A Narrative Review.Nutrients · 2026Review
- The role of lumbar core muscle morphology in residual chronic low back pain after PLIF: a retrospective analysis.Frontiers in surgery · 2026Article
- Hierarchical Evaluation of Predictive Models for Confirmed Sarcopenia: Discrimination, Calibration, and Clinical Applicability in a Cross-Sectional Study of Older Adults.Journal of clinical medicine · 2025Article
- Mediating role of possible sarcopenia in the association between diabetes and stroke: finding from the China health and retirement longitudinal study.BMC geriatrics · 2025Article
- Risk of sarcopenia in women with breast cancer: a comparative analysis of screening tools.BMC cancer · 2025Observational
- Low gait speed is better than frailty and sarcopenia at identifying the risk of disability in older adults.Age and ageing · 2025Article
- Frailty or sarcopenia: which is a better indicator of mortality risk in older adults?Journal of epidemiology and community health · 2025Article
- Development and content validity of the evaluation of multidimensional functioning and risks in aging scale.PeerJ · 2025Article
- SARCOPENIA AND GASTROINTESTINAL CANCER: NUTRITIONAL APPROACH FOCUSING ON CURCUMIN SUPPLEMENTATION.Arquivos de gastroenterologia · 2025Review
- How does the cut-off point for grip strength affect the prevalence of sarcopenia and associated factors? Findings from the ELSI-Brazil Study.Cadernos de saude publica · 2025Article
- Validity and reliability of Gripwise digital dynamometer in the assessment of handgrip strength in older adults.Frontiers in aging · 2025Article
- The Association Between Malnutrition, Sarcopenia, and Fracture Risk in Older Adults with Osteoporosis.Sisli Etfal Hastanesi tip bulteni · 2025Article
- Sarcopenia-associated factors and their bone mineral density levels in middle-aged and elderly male type 2 diabetes patients.World journal of diabetes · 2024Article
- Diagnostic accuracy of isometric knee extension strength as a sarcopenia criteria in older women.BMC geriatrics · 2024Article
- Can simple measures from clinical practice serve as a proxy for sarcopenic obesity and identify mortality risk?Aging clinical and experimental research · 2024Article
- Anthropometric equation has sufficient diagnostic capacity to identify sarcopenia in women with breast cancer.BMC cancer · 2024Article
- Diagnostic Criteria and Measurement Techniques of Sarcopenia: A Critical Evaluation of the Up-to-Date Evidence.Nutrients · 2024Review
- Pathophysiological-Based Nutritional Interventions in Cirrhotic Patients with Sarcopenic Obesity: A State-of-the-Art Narrative Review.Nutrients · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectivesto analyse the accuracy of grip strength and gait speed in identifying mortality; to compare the association between mortality and sarcopenia defined by the EWGSOP1 and EWGSOP2 using the best cut-off found in the present study and those recommended in the literature and to test whether slowness is better than these two definitions to identify the risk of death in older adults.
methodsa longitudinal study was conducted involving 6,182 individuals aged 60 or older who participated in the English Longitudinal Study of Ageing. Sarcopenia was defined based on the EWGSOP1 and EWGSOP2 using different cut-off for low muscle strength (LMS). Mortality was analysed in a 14-year follow-up.
resultscompared with the LMS definitions in the literature (<32, <30, <27 and < 26 kg for men; <21, <20 and < 16 kg for women), the cut-off of <36 kg for men (sensitivity = 58.59%, specificity = 72.96%, area under the curve [AUC] = 0.66) and < 23 kg for women (sensitivity = 68.90%, specificity = 59.03%, AUC = 0.64) as well as a low gait speed (LGS) ≤0.8 m/s (sensitivity = 53.72%, specificity = 74.02%, AUC = 0.64) demonstrated the best accuracy for mortality. Using the cut-off found in the present study, probable sarcopenia [HR = 1.30 (95%CI: 1.16-1.46)], sarcopenia [HR = 1.48 (95%CI: 1.24-1.78)] and severe sarcopenia [HR = 1.78 (95%CI: 1.49-2.12)] according to EWGSOP2 were better predictors of mortality risk than EWGSOP1. LGS ≤0.8 m/s was a better mortality risk predictor only when LMS was defined by low cut-off.
conclusionsusing LMS <36 kg for men and < 23 kg for women and LGS ≤ 0.8 m/s, EWGSOP2 was the best predictor for mortality risk in older adults.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.